Skip to content

Talkspace, Inc. TALK Price / sales

Price / sales at other companies

Teladoc Health logo
Teladoc HealthTDOC
0.4×-0.2×
LifeStance Health Group logo
LifeStance Health GroupLFST
1.6×-0.4×
US Physical Therapy logo
US Physical TherapyUSPH
1.4×-0.1×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.6×+0.3×
Astrana Health logo
Astrana HealthASTH
0.4×-0.2×
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
1.1×-0.4×

Other financials

Income statement

See full
Revenue$61.7M+18.2%
Gross profit$23.3M+7.1%
Operating income-$7.1M-557%
Net income-$6.3M-2,083%
EPS (diluted)-$0.04

Balance sheet

See full
Cash & equivalents$31.4M-47.7%
Total debt$466.0K
Total equity$113.1M-0.3%
Total assets$136.2M+1.5%

Cash flow

See full
Operating cash flow-$4.4M-257%
CapEx$385.0K+4,178%
Free cash flow$5.2M

Valuation

See full
Market cap$869.39M+93.9%
P/E743.7×+591×

Profitability

See full
Gross margin45%-4.0pp
Operating margin-1.2%
Net margin0.5%-1.0pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity1%-1.5pp
Debt / equity
Current ratio4.8×-1.6×

Where this comes from

Calculated from Talkspace, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Talkspace, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talkspace, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talkspace, Inc.'s price / sales?
Talkspace, Inc. (TALK) reported price / sales of 3.6× in Q1 2026.
How has Talkspace, Inc.'s price / sales changed year-over-year?
Talkspace, Inc.'s price / sales increased by 63.5% year-over-year, from 2.2× to 3.6×.
What is the long-term trend for Talkspace, Inc.'s price / sales?
Over 5 years (2020 to 2025), Talkspace, Inc.'s price / sales has grown at a -34.4% compound annual growth rate (CAGR), from 21.6× to 2.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.